PHARMACOKINETICS OF FT-ADM AFTER INTRAVENOUS ADMINISTRATION OF DA-125, A PRODRUG OF FT-ADM OR FT-ADM TO RATS - A NEW ADRIAMYCIN ANALOG CONTAINING FLUORINE

被引:18
作者
SHIM, HJ
LEE, ED
YOON, EJ
LEE, SD
KIM, WB
YANG, J
LEE, MG
机构
[1] SEOUL NATL UNIV,COLL PHARM,SEOUL 151742,SOUTH KOREA
[2] DONG A PHARMACEUT CO LTD,RES LAB,KYUNGGI DO 449900,SOUTH KOREA
关键词
PHARMACOKINETICS; DA-125; M1; M2; M3; M4; STABILITY; BLOOD PARTITIONING;
D O I
10.1016/0378-5173(94)90095-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of DA-125 or its active metabolite, M1 (FT-ADM), an adriamycin analog containing fluorine were compared after intravenous (i.v.) administration of DA-125 or M1 in rats. DA-125, 20 mg kg(-1) was dissolved in 1 mM lactic acid/0.9% NaCl solution (treatment I) or 100% dimethylsulfoxide (DMSO, treatment II), and M1, 20 mg/kg was dissolved in 100% DMSO (treatment III) due to its poor water solubility. The plasma concentrations of DA-125 and M1, and the pharmacokinetic parameters of DA-125, such as terminal half-life (t(1/2),1.64 vs 2.07 min), mean residence time (MRT, 1.52 vs 2.60 min), total body clearance (CL, 165 vs 186 ml min(-1) kg(-1)) and apparent volume of distribution at steady state (Vd(ss), 254 vs 411 ml kg(-1)), and of M1 (based on plasma data up to 1 h), such as t(1/2) (30.2 vs 38.7 min), MRT (19.1 vs 31.6 min), CL (187 vs 189 ml min(-1) kg(-1)) and Vd(ss) (2670 vs 5700 ml kg(-1)) were similar between treatments I and II, indicating that the effect of 100% DMSO on the pharmacokinetics of DA-125 or M1 seemed to be negligible, if any. The plasma concentrations of M1, and the pharmacokinetic parameters of M1 (based on plasma data up to 8 h when the dose of M1, 20 mg kg(-1) was normalized to the dose of DA-125, 20 mg kg(-1)), such as t(1/2) (255 vs 221 min), MRT (269 vs 235 min), CL (103 vs 112 ml min(-1) kg(-1)) and Vd(ss) (28500 vs 26300 ml kg(-1)) were also similar between treatments II and III. The above results indicate that DA-125 is rapidly hydrolyzed to M1 after i.v. administration of DA-125. Therefore, the estimation of the pharmacokinetic parameters of M1 after i.v. administration of DA-125 appeared not to cause any differences, if any when compared with the values after i.v. dose of M1. The rapid hydrolysis of DA-125 to M1 was demonstrated during an in vitro study; the t(1/2) values of hydrolysis of DA-125 were 1.97, 1.72, 0.54 and 0.54 min in the plasma from mouse, rat, dog and human, respectively, when the plasma containing DA-125 was incubated in a shaking water bath kept at 37 degrees C and at a rate of 300 rpm.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 17 条
[1]   ADRIAMYCIN - REVIEW [J].
CARTER, SK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) :1265-1274
[2]  
CHANG HW, 1988, SEOUL U J PHARM SCI, V13, P1
[3]   PHARMACOKINETICS OF DRUGS IN BLOOD III - METABOLISM OF PROCAINAMIDE AND STORAGE EFFECT OF BLOOD-SAMPLES [J].
CHEN, ML ;
LEE, MG ;
CHIOU, WL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (05) :572-574
[4]   NEW CALCULATION METHOD FOR MEAN APPARENT DRUG VOLUME OF DISTRIBUTION AND APPLICATION TO RATIONAL DOSAGE REGIMENS [J].
CHIOU, WL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1067-1069
[5]   CRITICAL EVALUATION OF THE POTENTIAL ERROR IN PHARMACOKINETIC STUDIES OF USING THE LINEAR TRAPEZOIDAL RULE METHOD FOR THE CALCULATION OF THE AREA UNDER THE PLASMA LEVEL TIME CURVE [J].
CHIOU, WL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (06) :539-546
[6]   EFFECTS OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE PRETREATMENT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF FUROSEMIDE IN RATS [J].
CHOI, YM ;
KIM, SH ;
LEE, MG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (07) :638-642
[7]  
Gibaldi M., 1982, PHARMACOKINETICS, Vsecond
[8]  
IIGO M, 1990, Anti-Cancer Drugs, V1, P77
[9]  
KIM MS, 1993, 2 C NEW DRUG DEV APR, P38
[10]  
Kitaura K, 1972, Jpn J Antibiot, V25, P65